Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia
Top Cited Papers
Open Access
- 1 July 2008
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 112 (1), 82-89
- https://doi.org/10.1182/blood-2007-11-121723
Abstract
Type 2 diabetes is associated with altered immune and hemostatic responses. We investigated the selective effects of hyperglycemia and hyperinsulinemKeywords
This publication has 39 references indexed in Scilit:
- Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysisBlood Coagulation & Fibrinolysis, 2007
- Neutrophil serine proteases: specific regulators of inflammationNature Reviews Immunology, 2006
- Hyperglycemia Stimulates Coagulation, Whereas Hyperinsulinemia Impairs Fibrinolysis in Healthy HumansDiabetes, 2006
- Intensive Insulin Therapy in the Medical ICUNew England Journal of Medicine, 2006
- Hyperglycemia enhances the cytokine production and oxidative responses to a low but not high dose of endotoxin in ratsCritical Care Medicine, 2005
- Bidirectional Relation Between Inflammation and CoagulationCirculation, 2004
- Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-α, and FFAs to low-dose endotoxemia in humansAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Disseminated Intravascular Coagulation in Trauma PatientsSeminars in Thrombosis and Hemostasis, 2001
- Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetesLife Sciences, 2000
- Type 2 diabetesCoronary Artery Disease, 1999